
- June 2017 Women's Health
- Volume 83
- Issue 6
Leveraging Patient Care Services to Optimize Patient Care in RA: A Pharmacist’s Opportunity
This Continuing Education activity is supported by an educational grant from Sandoz Inc.
This activity is supported by an educational grant from Sandoz Inc.
Faculty
Jeffrey D. Dunn, PharmD, MBACCO/SVPVRx, LLCVP MagellanRxSalt Lake City, UtahDouglas S. Burgoyne, PharmD,FAMCPSVP & Market GM MagellanRxSalt Lake City, Utah
Medical/Editing Support
Jessica MartinMartin Medical Writing, LLCSaint Paul, Minnesota
Educational Objectives
After completing this continuing education program, the participant will be able to:
- Examine current treatment options in rheumatoid arthritis (RA) and steps to address and/or minimize treatment failure
- Identify emerging treatment pathways in RA and associated pathways
- Explain the requirements necessary for a biosimilar agent to be approved for use
- Illustrate methods to improve care for patients with RA
Target audience: Pharmacists
Type of activity: Application
Release date: June 15, 2017
Expiration date: June 15, 2018
Estimated time to complete activity: 2.0 hours
Fee: Free
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-17-059-H01-P. The activity is available for CE credit through June 15, 2018.
Articles in this issue
over 8 years ago
Case Studies (June 2017)over 8 years ago
Can You Read These Rxs? (June 2017)over 8 years ago
Pet Peeves (June 2017)over 8 years ago
Generic Product News (June 2017)over 8 years ago
Naloxone Nasal Spray More Generics on the Horizon?over 8 years ago
Medication Therapy Management and Health Care Reformover 8 years ago
Mental Illness Linked to Heightened Cardiovascular Disease RiskNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































